The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 121

More JCP Articles

JCP
Original Research

October 25, 2017

Most studies to date have focused on the effects of mood stabilizers in bipolar I patients. This postmarketing surveillance study examines whether lamotrigine better prevents episodes in those with…
, , , et al
JCP
Original Research

October 24, 2017

Does rate of adherence to antidepressants vary much between physicians? This study of electronic health records and insurance claims data investigates the question, as well as whether adherence to…
, , , et al
JCP
Original Research

October 24, 2017

Therapeutic drug monitoring during clozapine therapy can be inconvenient as well as uncomfortable for patients. This study tested a novel method of dried blood spot (finger prick) monitoring as…
, , , et al
JCP
Original Research

October 24, 2017

Do second-generation antidepressants pose an increased risk of seizure? These authors used Taiwan’s national health insurance database to investigate the question, including whether dose or medication class affects the…
, , , et al
JCP
Original Research

October 17, 2017

Cognitive dysfunction in bipolar disorder is a strong predictor of disability, poor quality of life, and longer time to recovery. Could cognitive remediation, a behavioral intervention used successfully in…
, , , et al
JCP
Original Research

October 17, 2017

Placebo effects are a common obstacle in the search for Alzheimer’s disease treatments. This analysis of data from the large CATIE-AD study investigates ways to screen out potential placebo…
, , , et al
JCP
Original Research

October 17, 2017

Total prescription stimulant sales for adults have now surpassed those for youth, and targeting the misuse of these medications is important in order to reduce health and social consequences….
, , , et al
JCP
Original Research

October 10, 2017

Although anosognosia—or impaired illness awareness—is common in Alzheimer’s disease, it occurs less frequently in mild cognitive impairment. Read this article to learn if anosognosia in patients with mild cognitive…
, , , et al
JCP
Academic Highlights

October 10, 2017

Is your patient experiencing involuntary movements of the face, torso, or extremities? It could be tardive dyskinesia, a side effect of antipsychotic medications. Explore this CME Academic Highlights activity…
, ,
JCP
Original Research

October 3, 2017

Identification of physiologic biomarker precursors that result from prolonged psychological stress allows for possible prevention of negative outcomes; however, long-term data on the association of trauma with such biomarkers…
, , , et al
JCP
Article

October 3, 2017

Available data suggest that excess weight and obesity are associated with poorer cognitive functioning and numerous pathophysiologic changes in adults. This post hoc analysis sought to determine whether obesity…
, , , et al
JCP
Clinical and Practical Psychopharmacology

September 26, 2017

In this installment of his Clinical and Practical Psychopharmacology column, Dr Andrade provides a meta-review of 6 meta-analyses examining the risk of autism spectrum disorder associated with use of…

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe